A detailed history of Royal Bank Of Canada transactions in Argenx Se stock. As of the latest transaction made, Royal Bank Of Canada holds 35,612 shares of ARGX stock, worth $22.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,612
Previous 25,827 37.89%
Holding current value
$22.2 Million
Previous $11.1 Million 73.9%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$434.22 - $551.9 $4.25 Million - $5.4 Million
9,785 Added 37.89%
35,612 $19.3 Million
Q2 2024

Aug 14, 2024

BUY
$356.01 - $451.55 $105,378 - $133,658
296 Added 1.16%
25,827 $11.1 Million
Q1 2024

Nov 05, 2024

SELL
$356.95 - $413.29 $105,657 - $122,333
-296 Reduced 1.15%
25,531 $10.1 Million
Q1 2024

May 15, 2024

BUY
$356.95 - $413.29 $181,330 - $209,951
508 Added 2.03%
25,531 $10.1 Million
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $274,856 - $410,374
811 Added 3.35%
25,023 $9.52 Million
Q3 2023

Nov 14, 2023

BUY
$369.35 - $548.43 $473,506 - $703,087
1,282 Added 5.59%
24,212 $11.9 Million
Q2 2023

Aug 14, 2023

BUY
$360.14 - $422.58 $962,654 - $1.13 Million
2,673 Added 13.2%
22,930 $8.94 Million
Q1 2023

May 15, 2023

BUY
$334.23 - $403.65 $189,508 - $228,869
567 Added 2.88%
20,257 $7.55 Million
Q4 2022

Feb 14, 2023

SELL
$342.17 - $402.31 $239,176 - $281,214
-699 Reduced 3.43%
19,690 $7.46 Million
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $883,053 - $1.02 Million
2,573 Added 14.44%
20,389 $7.2 Million
Q2 2022

Aug 15, 2022

BUY
$269.58 - $378.88 $1.54 Million - $2.16 Million
5,696 Added 47.0%
17,816 $6.75 Million
Q1 2022

May 16, 2022

BUY
$254.45 - $351.06 $1.95 Million - $2.69 Million
7,671 Added 172.42%
12,120 $3.82 Million
Q4 2021

Feb 14, 2022

SELL
$272.01 - $353.03 $1,360 - $1,765
-5 Reduced 0.11%
4,449 $1.56 Million
Q3 2021

Nov 15, 2021

SELL
$295.0 - $350.58 $26,255 - $31,201
-89 Reduced 1.96%
4,454 $1.35 Million
Q2 2021

Aug 16, 2021

BUY
$257.11 - $319.92 $1.17 Million - $1.45 Million
4,543 New
4,543 $1.37 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.5B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.